Allergy
Five things for pharma marketers to know: Monday, October 16, 2017
October 16, 2017FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified
Bayer's Claritin campaign encourages time outdoors
May 04, 2017Claritin is fighting the "indoor epidemic" with its Be an Outsider campaign
Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years
August 31, 2016In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.
Five things for pharma marketers to know: Monday, August 29, 2016
August 29, 2016Mylan to launch generic EpiPen; the majority of NCCN guideline writers report conflicts of interest; Sanofi reports new trial data for Praluent
Five things for pharma marketers to know: Friday, August 26, 2016
August 26, 2016Sarah Jessica Parker cuts ties with Mylan over pricing controversy; lung-cancer physicians turn to Keytruda; Merck KGaA diversifies its business
Five things for pharma marketers to know: Thursday, July 7, 2016
July 07, 2016EpiPen price hikes led to syringe use; states with medical marijuana laws have drops in drug spending; Pfizer and Merck KGaA start ovarian cancer trial
GSK's Flonase tops allergy category
June 01, 2015The new OTC medication almost hit $100 million in sales in its first 16 weeks on the market.
WebMD: Pollen Vortex is here
May 13, 2014The medical website says the country is in for a bad allergy season.
Tuesday: FDA panel reviews Merck's Ragwiteck
January 27, 2014Preliminary documents suggest a positive view for the under-the-tongue medication.
Shutdown delays some FDA committees
October 09, 2013User fees keep the regulator's review process running for some drugs, while others see review dates slip.
Mylan expands Get Schooled anaphylaxis tool box
September 19, 2013The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.
Business briefs: Sanofi, Celgene, plus changing cancer definitions
July 30, 2013Sanofi may make OTC history; Celgene joins a new collaboration; and the US Task Force of Preventative Medicine wants to make lung cancer screening the norm
Finding opportunity in FDA focus on drugged driving
June 19, 2013With its recent actions on sleep aids and allergy medications, the FDA is demonstrating growing concern about the effects of prescription drugs on driving. One CRO is fielding a fleet of driving simulators to help manufacturers salve the agency's worries.
Ex-NFLer, Sanofi talk anaphylaxis
May 20, 2013The company's latest outreach, an Auvi-Q promotion, breaks down allergy management into sports playbook presentation.
Mylan expands Epi-Pen strategy
September 27, 2012Emmy-winner Julie Bowen is part of the effort to spread allergy education and awareness in schools.
Sanofi's talking allergy device an answer to Dey's EpiPen
August 14, 2012The drugmaker's new auto-injecting epinephrine pen provides verbal cues during emergency allergic situations. It's the latest entry in a competitive market.
Dey launches EpiPen app
January 26, 2011Mylan's Dey Pharma launched MyEpiPen App, designed to help patients with severe allergies and their caregivers cope with episodes of anaphylaxis.
